Ignite Creation Date:
2024-05-05 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00361387
Status:
COMPLETED
Last Update Posted:
2011-02-24
First Post:
2006-08-07
Brief Title:
Use of Focalin for Fatigue in Sarcoidosis
Sponsor:
University of Cincinnati
Organization:
University of Cincinnati
Study Overview
Official Title:
Randomized Double-Blind Placebo-Controlled Study of Dexmethylphenidate Hydrochloride d-MPH in the Treatment of Fatigue in Sarcoidosis Subjects
Status:
COMPLETED
Status Verified Date:
2011-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Patients diagnosed with chronic sarcoidosis with fatigue for more than 6 months Sarcoidosis and its treatment can greatly affect your quality of life Many patients suffer from fatigue feeling tired lack of focus and concentration in ability to organize their daily activities and memory loss These commonly reported symptoms often get in the way of everyday life
Detailed Description:
This is to be a double blind randomized trial with cross over of 12 patients with chronic sarcoidosis on stable systemic therapy Patients will be screened for fatigue using a modified SNAP and Facit-F scores Patients will be in the study for 20 weeks Objective of study To determine the effect of dexmethylphenidate hydrochloride d-MPHFocalin on fatigue in Sarcoidosis The is a common complaint in sarcoidosis related to the chronic inflammatory nature of the disease It may also related to therapy for the disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None